Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Production of SV40 Viral Vectors for Targeted Integration into Cells: Advancing Gene Therapy More
Establishment of Novel Stable Virus Packaging Cell Lines: Application in Gene Therapy Treatment More
Monoclonal Antibodies Against Capsids of Adeno-Associated Virus (AAV) Serotypes More
Chimeric Mutation Vectors having Non-Natural Nucleotides: Introducing Specific Changes in the Genome of a Eukaryotic Cell More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2009 - 90 pages - $3,800
Mar 2011 - 34 pages - $500
Mar 2011 - 24 pages - $750
Nov 2011 - 6 pages - $75
Mar 2011 - 26 pages - $500
Dec 2010 - 16 pages - $500
Jul 2010 - 20 pages - $750
Jul 2010 - 19 pages - $750
Jul 2010 - 24 pages - $750
Oct 2008 - 80 pages - $7,600
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us